Tuesday 30th July 2019
|Text too small?|
Abano Healthcare’s annual net profit dropped 26 percent, reflecting falling margins in both New Zealand and Australia and as it wrote off goodwill on four Australian dental practices.
The company also slashed its final dividend to 8 cents per share from 20 cents last year, taking the annual payout to 24 cents, down from 36 cents – Abano had held its first-half dividend steady at 16 cents.
The corporate dental group’s net profit fell to $7.6 million in the year ended May from $10.3 million the previous year. The underlying net result was down 18 percent.
The latest bottom line result included a $2.6 million write-off of goodwill, partly offset by a write-back of $1.1 million of performance-based deferred payment for recent practice acquisitions which won’t now be paid.
The company bought 16 more practices in the year, mostly in Australia, which took total practices to 239.
In line with its March announcement, Abano has reduced the number of practices it will buy and is trying to achieve organic growth.
It did achieve growth in New Zealand where its Lumino-branded practices delivered 1.2 percent gross revenue growth from practices owned at least a year, down from the 3.3 percent growth in the previous year.
However, that growth came at a cost with Lumino’s underlying earnings before interest, tax, depreciation and amortisation falling 12 percent to $16.9 million from $19.2 million the previous year and its ebitda margin dropping to 11.5 percent from 13.9 percent.
Abano says it invested significantly in Lumino’s IT, people and systems during the year to support the group’s scale and growth initiatives and that margins should return to prior levels in future.
While the Australian Maven brand saw revenue drop 2.9 percent after a flat performance the previous year, its ebitda rose 15.4 percent to A$19.5 million from A$16.9 million, despite its ebitda margin falling to 10.9 percent from 11.1 percent.
“The challenging economic conditions noted in Australia since 2014 have continued and, along with workforce and other business factors, have impacted on Maven Dental Group,” the company says.
“Abano is adapting its growth strategy to suit market conditions and implementing initiatives to lift business performance,” it says.
The company says it will save about $1.8 million in direct and indirect acquisition costs by reducing the number of dental practices it buys and that it has “resized” the support offices in both countries.
It says it expects an earnings recovery in the current year, “driven by continued same-store sales growth in New Zealand, the full-year benefits of full-year 2019 acquisitions and contributions from further New Zealand acquisitions expected in the second half of the 2020 financial year.”
Abano shares decreased 0.5 percent to $4.40 at today's opening and have fallen more than 50 percent in the last 12 months. The company has fought off numerous takeover attempts but the share price is now well below the $9.84 per share offered for a partial takeover bid that lapsed in March 2017.
No comments yet
Gold price hits $2,000 for first time on Covid
TruScreen strengthens its market presence in central and eastern Europe
Refining NZ announces non-cash impairment
Ryman Healthcare COVID-19 update Victoria
Talisman Quarterly Activities Report to 30 June 2020
General Capital gives notice of Annual Meeting
Scales Corporation - Business Update
Fonterra Co-operative Group Global Dairy Update
Fonterra revises its 2019/20 and 2020/21 forecast Farmgate Milk Price ranges
Briscoe Group Limited Market update: 2nd Quarter Sales to 26 July 2020